贝那普利联合美托洛尔治疗老年原发性高血压合并心力衰竭的临床分析
2019-08-19石家冲
石家冲

【摘要】 目的:讨论贝那普利联合美托洛尔治疗老年原发性高血压合并心力衰竭的临床效果。方法:于2018年1-9月选取笔者所在医院的
64例老年原发性高血压合并心力衰竭患者作为本文的研究对象,随机将64例患者分为对照组(贝那普利)与研究组(贝那普利+美托洛尔),将血压及心率指标作为评判标准。结果:治疗前,两组患者的血压及心率指标比较,差异均无统计学意义(P>0.05);治疗后,研究组患者的血压及心率指标均明显优于对照组(P<0.05);两组患者不良反应发生率对比,差异无统计学意义(P>0.05)。结论:贝那普利+美托洛尔治疗方案的实施对于老年原发性高血压合并心力衰竭疾病的治疗具有良好的治疗效果,值得推广。
【关键词】 贝那普利; 美托洛尔; 老年原发性高血压; 心力衰竭
doi:10.14033/j.cnki.cfmr.2019.16.051 文献标识码 B 文章编号 1674-6805(2019)16-0-03
【Abstract】 Objective:To discuss the clinical effect of Benazepril combined with Metoprolol in the treatment of senile primary hypertension with heart failure.Method:From January to September 2018,64 senile patients with primary hypertension with heart failure in our hospital were selected as subjects of this study.The 64 patients were randomly divided into the control group(Benazepril) and the study group(Benazepril combined with Metoprolol).Result:Before treatment,blood pressure and heart rate of the two groups were compared,the differences were not statistically significant(P>0.05).After treatment,the patients blood pressure and heart rate index of the study group were significantly better than those of the control group(P<0.05).The incidence of adverse reactions was compared between the two groups,the difference was not statistically significant(P>0.05).Conclusion:The implementation of Benazepril combined with Metoprolol treatment program has a good effect on the treatment of senile primary hypertension with heart failure disease,and it is worthy to be popularized.
【Key words】 Benazepril; Metoprolol; Senile primary hypertension; Heart failure
First-authors address:Qianjiang Central Hospital,Qianjiang 433100,China
高血压在临床上是一种常见的慢性疾病,属于诱发各类心脑血管疾病的重要性因素之一,原发性高血压作为高血压疾病中的一种类型,其发病较为隐匿,且病情進展速度较为缓慢,病程持续时间长,发病初期,患者并不会出现明显的临床症状表现,直至患者的病情进一步加重时,其会出现有头晕、失眠以及头胀等不良症状[1-2]。情况严重者,还有可能引起严重的并发症,例如心力衰竭等,可直接威胁到患者的生命安全,对于原发性高血压合并心理衰竭患者来说,控制好患者的血压指标,改善其心功能是治疗该病的关键,对此,本文对给予患者贝那普利与给予患者贝那普利+美托洛尔的临床治疗效果资料进行了分析,详情见下文。……p>
